News | August 23, 2011

Results Published for REMEDIAL II Italian Trial of RenalGuard Therapy

August 23, 2011 — PLC Systems Inc. said the final results from the REMEDIAL II investigator-sponsored clinical trial have been published online in Circulation, a peer-reviewed journal of the American Heart Association. It will appear in the September 2011 issue of the publication. REMEDIAL II is an Italian trial of the company’s RenalGuard device.

Results showed RenalGuard is superior to current methods at preventing contrast-induced nephropathy (CIN) and in-hospital dialysis in high-risk patients undergoing computed tomography (CT) and angiography imaging procedures. All patients also received injections of iodine-based contrast agents.

Investigators discovered patients treated with RenalGuard and N-acetylcysteine (NAC) developed CIN, a serious and potentially fatal condition, at a much lower rate than patients in the control group. The second group was treated with an infusion of sodium bicarbonate and NAC. Sodium bicarbonate plus NAC remains the current standard-of-care for the prevention of CIN in many healthcare institutions worldwide.

The results provided strong scientific data that RenalGuard therapy is superior to sodium bicarbonate and N-acetylcysteine in preventing contrast-induced acute kidney injury (CI-AKI) in high-risk patients.

Carlo Briguori, M.D., Ph.D., chief of laboratory of interventional cardiology, Clinica Mediterranea, Naples, Italy, reported on data from 294 patients with chronic kidney disease (CKD). All patients also underwent elective catheterization procedures for diagnostic imaging.

The primary endpoint for the study used a definition of CIN as a rise in serum creatinine (SCr) of 0.3 mg/dl over the patient's baseline reading. The RenalGuard group had a CIN incidence rate 46 percent lower than the control group using this definition of CIN. He also reported on a number of secondary endpoints. There was a 60 percent reduction in CIN in the RenalGuard group compared to the control group when defining CIN as a 0.5 mg/dl absolute rise in SCr. There was an 80 percent reduction of CIN in the RenalGuard-treated group over the control group when defining CIN as a 25 percent rise over baseline SCr.

The development of CIN has been found to lead to a range of serious and potentially deadly outcomes in patients who already have compromised kidney function. Notably the trial also found RenalGuard therapy significantly reduced the need for in-hospital dialysis in high-risk patients. In the control group, seven (or 4.8 percent) of these patients required some level of dialysis. Only one patient (0.7 percent), or 85 percent fewer, in the RenalGuard-treated group required dialysis.

The Circulation article can be accessed at the following link: http://circ.ahajournals.org/content/early/2011/08/13/CIRCULATIONAHA.111.030759.abstract

For more information: www.plcmed.com

Related Content

Brain Imaging Predicts Language Learning in Deaf Children
News | Magnetic Resonance Imaging (MRI) | January 23, 2018
January 23, 2018 – In a new international collaborative...
Imricor Announces Enrollment Completion for Clinical Study on Vision-MR Ablation Catheter
News | Interventional Radiology | January 23, 2018
January 23, 2018 – Imricor Medical Systems announced completion of enrollment for the...
Siemens Healthineers, Florida Hospital Collaborate to Improve Health Care Outcomes
News | CT Angiography (CTA) | January 23, 2018
January 23, 2018 – Siemens Healthineers and Florida Hospital, part of Adventist Health System, have announced a multi
Hospital for Special Surgery Invests in Sectra Orthopedic 3-D Planning Software
News | Orthopedic Imaging | January 18, 2018
January 18, 2018 – International medical imaging IT and cybersecurity company Sectra announces that Hospital for Spec
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Smartphone Addiction Creates Imbalance in Brain
News | Mobile Devices | January 11, 2018
Researchers have found an imbalance in the brain chemistry of young people addicted to smartphones and the internet,...
Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
News | Women's Health | January 11, 2018
January 11, 2018 – It’s not the amount of fat in your body but where it is stored that may increase your risk for hea
Emergency Radiologists See Inner Toll of Opioid Use Disorders

Rates of Imaging Positivity for IV-SUDs Complications. Image courtesy of Efren J. Flores, M.D.

News | Clinical Study | January 11, 2018
January 11, 2018 – Emergency radiologists are seeing a high prevalence of patients with complications related to opio
Overlay Init